Disease relevance of Infusion Pumps, Implantable

• Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump [1].
• Outpatient dobutamine infusion using a totally implantable infusion pump for refractory congestive heart failure [2].

High impact information on Infusion Pumps, Implantable

• Currently prescribed doses of HMG-CoA reductase inhibitors given orally or continuously by an implantable infusion pump could achieve tumour therapeutic tissue concentrations of these agents [3].
• We conclude that near-normal blood glucose concentrations can be maintained throughout the day in the dog by these means and that similar approaches, using implantable infusion pumps, in man may lead to better long-term control of diabetes than is currently available [4].
• The Infusaid implantable infusion pump with a single delivery rate has maintained chronic intravenous heparin infusion in man for greater than 35 mo and for greater than 5 yr in the dog [5].
• Stability of meperidine in an implantable infusion pump using capillary gas chromatography-mass spectrometry and a deuterated internal standard [6].
• This new, simple, implantable infusion pump can serve as an economical vehicle for prolonged parenteral drug treatment of ambulatory subjects in circumstances where continuous single-rate infusion is appropriate [7].

Anatomical context of Infusion Pumps, Implantable

• During a five year period, 69 patients were treated for carcinoma of the liver (seven primary tumors and 62 metastatic tumors) with 5-fluorodeoxyuridine (5-FUDR) administered through a hepatic artery (n = 62) or portal vein (n = 3) implantable infusion pump [8].

Associations of Infusion Pumps, Implantable with chemical compounds

• Continuous intrathecal meperidine via an implantable infusion pump for chronic, nonmalignant pain [9].

References